FIGURE 3.
Independent prognostic analysis and nomogram of the 8-lncRNA prognostic signature. (A) Univariate Cox regression of the TCGA cohort. (B) Multivariate Cox regression of the TCGA cohort based on overall survival. Age (>65 vs. ≤65), gender (male vs. female), stage (III/IV vs. I/II), T (III/IV vs. I/II), M (I vs. 0), N (I/II vs. 0), KRAS (mutation vs. wild), TP53 (mutation vs. wild), BRAF (mutation vs. wild), POLE (mutation vs. wild), and risk (low-risk vs. high-risk). (C) Nomogram of the TCGA cohort based on overall survival (M was not included in the nomogram due to only 20 patients with M1). (D) Calibration curve of the TCGA cohort based on overall survival at 1, 2, and 3 years.
